No-Touch Saphenous Veins in Coronary Artery Bypass Grafting.
Long-term Angiographic, Surgical, and Clinical Aspects.
To my wife, Sara for her patience and love; to my children Oliver and Nora who make everything worthwhile; and to my parents who have al-
ways supported me.
We learn something every day, and lots of times it’s that what we learned the day before was wrong.
—Bill Vaughan
Örebro Studies in Medicine 145
N INOS S AMANO
No-Touch Saphenous Veins in Coronary Artery Bypass Grafting.
Long-term Angiographic, Surgical, and Clinical Aspects.
© Ninos Samano, 2016
Title: No-Touch Saphenous Veins in Coronary Artery Bypass Grafting.
Long-term Angiographic, Surgical, and Clinical Aspects.
Publisher: Örebro University 2016 www.oru.se/publikationer-avhandlingar
Print: Örebro University, Repro 05/2016 ISSN 1652-4063
ISBN 978-91-7529-137-6
Abstract
Ninos Samano (2016): No-Touch Saphenous Veins in Coronary Artery Bypass Grafting. Long-term Angiographic, Surgical, and Clinical Aspects. Örebro Studies in Medicine 145.
Ischemic heart disease is currently the leading cause of death globally. Coronary artery bypass grafting (CABG) is considered the best treatment for many patients and its success depends on the long-term patency of the conduits. Greater use of arterial grafts has been advocated because of their higher long-term patency compared to saphenous vein grafts (SVGs). Despite this, SVGs account for up to 80% of all grafts used in CABG. Consequently, the long-term patency of the saphenous vein (SV) is one of the most crucial challenges in cardiovascular sur- gery. The no-touch (NT) SV in CABG has shown a superior patency rate, slower progression of atherosclerosis, and better clinical outcome compared to conven- tional veins up to 8.5 years postoperatively. The aim of this thesis was to study the long-term angiographic, echocardiographic, and clinical aspects of CABG patients receiving either NT or conventional vein grafts and to investigate the health-related quality of life (HRQoL) in this patient group. Studies I-II report a randomized trial between NT and conventional veins where 74 patients were followed-up at a mean of 16 years postoperatively. Study III is a prospective cohort trial in which 97 patients with NT vein grafts anastomosed to the left anterior descending artery (LAD) were included and followed-up at a mean of 6 years postoperatively. Study IV included 257 patients in whom HRQoL and graft patency were studied during the same follow-up visit. Overall, NT vein grafts showed a higher patency compared to conventional veins at a mean of 16 years, 83% vs. 64% (p=0.03), which was similar to the patency of the left internal thoracic artery, 88%. The NT group had a better left ventricular ejection fraction compared to the conventional group, 57.9% vs. 49.4%
(p=0.011). After a mean of 6 years, the patency rate of NT SVs to the LAD was 95.6% and to non-LAD targets, 93.9%. Graft patency was an independ- ent predictor of HRQoL in CABG patients. These patients reported a func- tion and wellbeing similar to that of the Swedish population and clearly higher health status than those in the same disease group in the general popu- lation.
Keywords: Computed tomography angiography, coronary artery bypass grafting, left internal thoracic artery, no-touch harvesting technique, patency, saphenous vein.
Ninos Samano, Department of Cardiothoracic and Vascular Surgery, Örebro
University, SE-701-82 Örebro, Sweden; ninos.samano@regionorebrolan.se
Table of Contents
−
−
Abbreviations
10
Original papers
Presentations
12
Introduction
The history of coronary artery bypass surgery
The current state of development
14
The left internal thoracic artery
Left internal thoracic artery (LITA)
Circumflex coronary artery (CX) Diagonal branch of the LAD Left anterior descending artery (LAD) Aorta
Saphenous vein graft (SVG) to the CX SVG to the RCA
Right coronary artery (RCA)
Saphenous vein grafts
The conventional harvesting technique
16
The no-touch harvesting technique
18
Health-related quality of life
Aims
20
Materials and methods
Studies I−II
Study design
Angiography
22
156 patients randomized Harvesting techniques
Conventional (52) Intermediate (52) No-touch (52)
(1.5 years) 46 patients 41 patients 45 patients
(8.5 years) 37 patients + (5) 37 patients + (5)
42 patients 42 patients
(16 years) 27 patients (72 grafts) 27 patients (75 grafts)
6 declined
No deaths No deaths 11 declined No deaths 7 declined
5 declined
4 deaths 3 deaths 5 declined
4 sick, 1 lost to follow-up 10 deaths
2 lost to follow-up 10 deaths
3 had renal failure No follow-up due to
financial limitations
& lowest patency at 1.5 years
Echocardiographic evaluation
Clinical evaluation
Statistical analysis
24
Study III
Study design
26
Angiography
Clinical evaluation
Statistical analysis
28
Study IV Study
population
30
Surgical aspects and graft patency
European quality of life-5 dimensions instrument
Statistical analysis
32
Study I
Post-mortem biopsies
34
Results
Angiography
36
Conventional group (C) No-touch group (N T) 1.5 yrs (n =1 2 7 ) 8.5 yrs (n=101) 16 yrs (n=72) 1.5 yrs (n=124) 8.5 yrs (n=101) Graft flow �40(mL/min) 48/56 (86) 37/50 (74) 18/33 (55) 56/61 (92) 44/46 (96) >40(mL/min) 64 /71 (90) 41/51 (80) 28/39 (72) 62/63 (98) 48/55 (87) Coronary artery <2.0 mm 66/78 (85) 47/64 (73) 28/43 (65) 89/94 (95) 73/78 (94)
dian1eter�2.0 mm 46/49 (94) 31/37 (84) 18/29 (62) 29/30 (97) 19/23 (83) Coronary artery Good 93/106 (88) 6 6/ 84 (79) 42/63 (67) 100/106 (94) 77/86 (90) q ua li ty Mildly ca lc if ie d 16/17 (94) 10/14 (71) 4/8 10/10 8 /8 (100) Moderate 1 /2 1/2
Oil8 /8 7 /7 Occluded 2 /2 1 /1 0 /0 0 /0 0 /0 V en o us q ual it y Good 106/116 (91) 74/90 (82) 43/64 (67) 88/91 (97) 68/74 (92) Poor 6/11 (55) 4/11(36) 3/8 (38) 30/33 (91) 24/27 (89)
Saphenous veinD is tal 42/45 (93) 29/36 (81) 19/26 (73) 43/45 (96) 35/37 (95) Medial 40/45 (89) 28/36 (78) 16/26 (62) 42/45 (93) 32/37 (87) Proximal 30/37 (81) 21/29 (72) 11/20 (55) 33/34 (97) 25/27 (93) Coronary system ex 41/47 (87) 28/39 (72) 18/29 (62) 44/47 (94) 33/36 (92) DIAG 31/36 (86) 21/29 (72) 11/18 (61) 35/38 (92) 31/32 (97) LAD
2120 /0 1 /1 1 /1 1 /1 Right 14/16 (87) 10/12 (83) 7111 13/13 (100) 6/10 PDA 24/26 (92) 19/21 (91) 9/13 (69) 25/25 (100) 21/22 (95)
CX=circumflex artery; Diag=diagonal artery; LAD=left anterior descending artery; P DA=/Josterior descending artery; Right= right coronary artery.16 yrs (n=75)
29136(81 I 33/39 (85) 49/57 (86) 13/18 (72) 52/64 (81) 7/8 3 /3 0 /0 46/57 (8 1 ) 16/18 (8 9 ) 21/27 (7 8 ) 22/27 (8 1 ) 19/21 (9 0 ) 21/27 (7 8 ) 21124 (88 I 0 /0 4/7 16/17 (94 )
NINOS SAMANO
NO-TOUCH SAl'HicNOUS V121NS lNCABG 37
36
36
36
36
36
Conventional group (C)No-touch group (NT) 1.5 yrs (n=127 )8.5 yrs (n=101)16 yrs (n=72)1.5 yrs (n=124)8.5 yrs (n=101)16 yrs (n=75) Graft flow
≤40(mL/min) >40(mL/min) 48/56 (86) 64/71 (90) 37/50 (74) 41/51 (80) 18/33 (55) 28/39 (72) 56/61 (92) 62/63 (98) 44/46 (96) 48/55 (87) 29/36 (81) 33/39 (85) Coronary artery diameter<2.0 mm ≥2.0 mm
66/78 (85) 46/49 (94) 47/64 (73) 31/37 (84) 28/43 (65) 18/29 (62) 89/94 (95) 29/30 (97) 73/78 (94) 19/23 (83)
49/57 (86) 13/18 (72) Coronary artery quality
Good Mildly calcified Moderately calcified Occluded
93/106 (88) 16/17 (94) 1/2 2/2
66/84 (79) 10/14 (71) 1/2 1/1
42/63 (67) 4/8 0/1 0/0
100/106 (94) 10/10 8/8 0/0
77/86 (90) 8/8 (100) 7/7 0/0
52/64 (81) 7/8 3/3 0/0 Venous quality Good Poor
106/116 (91) 6/11 (55) 74/90 (82) 4/11(36) 43/64 (67) 3/8 (38) 88/91 (97) 30/33 (91) 68/74 (92) 24/27 (89)
46/57 (81) 16/18 (89) Saphenous vein Distal Medial Proximal
42/45 (93) 40/45 (89) 30/37 (81) 29/36 (81) 28/36 (78) 21/29 (72) 19/26 (73) 16/26 (62) 11/20 (55) 43/45 (96) 42/45 (93) 33/34 (97) 35/37 (95) 32/37 (87) 25/27 (93)
21/27 (78) 22/27 (81) 19/21 (90) Coronary systemCX DA LAD RCA PDA
41/47 (87) 31/36 (86) 2/2 14/16 (87) 24/26 (92)
28/39 (72) 21/29 (72) 0/0 10/12 (83) 19/21 (91)
18/29 (62) 11/18 (61) 1/1 7/11 9/13 (69)
44/47 (94) 35/38 (92) 1/1 13/13 (100) 25/25 (100)
33/36 (92) 31/32 (97) 1/1 6/10 21/22 (95)
21/27 (78) 21/24 (88) 0/0 4/7 16/17 (94) CX=circumflex artery; DA=diagonal artery; LAD=left anterior descending artery; PDA=posterior descending artery; RCA= right coronary artery.
38
Equivalence
Study II
Clinical characteristics
40
Echocardiography
42
Clinical outcome
44
Study III
46
Baseline and perioperative characteristics
48
Clinical outcome
Angiography
50
‼
ᶲ
52
‼
ᶲ